Teva Fails Late-Stage Trial In Migraine Trial 6/18/18

Discussion in 'Teva Respiratory' started by anonymous, Jun 18, 2018 at 7:51 AM.

Tags: Add Tags

  1. anonymous

    anonymous Guest

  2. anonymous

    anonymous Guest

    Keep telling yourself that LOLOL
     
  3. anonymous

    anonymous Guest

    The dosing alone will make Teva’s product very appealing. The trials and outcomes have been very intriguing and positive. I am anxious to see how some of my patients respond.

    Sincerely,
    Dr. Scott Mclung
    Rivers Pediatrics
     
  4. anonymous

    anonymous Guest


    Thanks Dr. Mclung and don't pay any attention to these posts. We all know it's just those Amgen and Norvartis reps trolling this site trying to stir the pot. The data will speak for itself and patients will quickly be making the switch to Ajovie at launch.
     
  5. anonymous

    anonymous Guest

    You dumb ass - doctors don’t come and post to this site!!!!
     
  6. anonymous

    anonymous Guest

    We also agree with Dr Mclung.

    Sincerely,
    Dr. Boris Mcbrain
    Dr. Bethany Mcheart
     
  7. anonymous

    anonymous Guest

    Doctors do not visit this site and definitely do not post. Idiots!!!!